GMDA News and Press, Gamida Cell Ltd. From 01/07/22

Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to cures for cancer and other serious diseases, today announced eight presentations at the 2022 Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR Tandem Meetings (TCT) being held in Salt La...

Gainers: Altamira Therapeutics (NASDAQ:CYTO) +37%. Takung Art (NYSE:TKAT) +34%. ShiftPixy (NASDAQ:PIXY) +37%. Pop Culture (NASDAQ:CPOP) +36%. Insignia Systems (NASDAQ:ISIG) +19%. Siyata (NASDAQ:SYTA) +16%. Calix (NYSE:CALX) +15%. WISeKey (NASDAQ:WKEY) +12%. Biofrontera (NASDAQ:BFRI) +13%. Law...

Gainers: MedAvail (NASDAQ:MDVL) +17%, Altamira Therapeutics (NASDAQ:CYTO) +17%, Orchard Therapeutics (NASDAQ:ORTX) +10%,Biofrontera (NASDAQ:BFRI) +9%, XORTX Therapeutics (NASDAQ:XRTX) +7%. Losers: Chembio Diagnostics (NASDAQ:CEMI) -16%, Gamida Cell (NAS...

3 Penny Stocks That Exploded During Today’s Trading Finding penny stocks that exploded or could explode is one of the best ways to make a potential profit in the stock market. However, to find penny stocks before they explode is where the large challenge comes in. As a result...

Gainers: Insignia Systems (NASDAQ:ISIG) +83%.. Pop Culture (NASDAQ:CPOP) +24%. Regencell Bioscience RGC +20% BridgeBio Pharma BBIO +19%. Gamida Cell (NASDAQ:GMDA) +17%. ADDvantage Technologies (NASDAQ:AEY) +17%. Centogene (NASDAQ:CNTG) +14% Altamira Therapeu...

Data from patients with NHL treated in Phase 1 investigator-led study of GDA-201 demonstrates median duration of response of 16 months; safety outcomes consistent after two years Poster presentation highlights reductions in hospitalization and healthcare resource utilization...

Oral presentation demonstrated rapid and sustained T cell and B cell recovery following transplantation with omidubicel in a subset of patients in Phase 3 study, providing mechanistic support for reducing viral infections Additional poster presentation highlighting long-term...

The following slide deck was published by Gamida Cell Ltd. in conjunction with their 2021 Q3 earnings call. For further details see: Gamida Cell Ltd. 2021 Q3 - Results - Earnings Call Presentation

Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to cures for blood cancers and serious blood diseases, today announced that company management will present its corporate highlights at the following upcoming virtual investor conferences: Evercore ISI 4 ...

Image source: The Motley Fool. Gamida Cell Ltd. (NASDAQ: GMDA) Q3 2021 Earnings Call Nov 15, 2021 , 8:00 a.m. ET Operator Continue reading For further details see: Gamida Cell Ltd. (GMDA) Q3 2021 Earnings Call Transcript